Challenges in Drug Development

Can your drug development operating model adapt to rapidly changing modalities and potential disruptions?

Drug discovery is an incredibly complex process with multiple points of failure, particularly in the earliest stages of building a new company.To maintain profitable and resilient operations, the C-suite of biotech companies may need to make bold changes to their operations strategy as the industry navigates through an evolution of challenges. Factors such as pandemics, inflation, geopolitics, new therapeutic modalities, and new ways of working make it vital for C-Suites to carefully reconsider their long-term choices in talent retention, sourcing, manufacturing, and supply chain. C-suites will need to prioritize efforts and provide adequate resourcing - navigating their organization, steer their company’s effort, gather the right skills and teams, and manage complex interdependencies. Succeeding in the industry under these new and challenging conditions will require succeeding in operations.

Our Value Proposition

Capsicure LLC, is a Full-Service Clinical Trials CRO, powered by Intelligence and guided by Wisdom.We are a Clinical R&D accelerator with a mission to help the biotech community through all stages of drug and device development by accelerating their milestones through our dilutive and non-dilutive capital investment offerings, payment solutions, strategic regulatory navigation and supporting clinical trials development, respectively.Through the deployment of our customized strategies that adapts to your project needs all while minimizing operational challenges, silos and costs - Capsicure can optimize your operational needs to respond to these trends and help you remain lean through the process and accelerate your ideas.Our tailored CRO solution delivers the complete ecosystem of CRO services, site operations and technology necessary to operate a study. Capsicure equips medical device sponsors with all the tools they need to quickly execute clinical trials at every phase. It starts with building your protocol, delivering your data, and assist in your publication.Our bold and innovative vision can position your organization to take advantage of the industry’s remarkable growth by advancing innovation, facilitating calculated risks and maximizing your financial viability while still delivering excellent quality data.

DIRECTION DETERMINES DESTINATION.

• Our Solution

CURATVLY

Introduction to our Virtual Clinical Trial Models

With “CURING” and being “CREATIVE” as part of the focal point our our 360° turn-key approach to executing any clinical trial, CURATVLY offers operational, regulatory and other centralized research support services for sites on industry-sponsored and investigator-initiated trials. With access to a broad patient base, CURATVLY can provide facilitation to conduct and support phase I through III and outcomes-based trials throughout its network of sites.The CURATVLY approach provides support services for trials across all therapeutic areas such as, Dermal/ Wound Healing, Cardiovascular, Endocrine, Metabolism, Gastroenterology, Immunology, Inflammation, Infectious Diseases, Vaccines, Ophthalmology, Respiratory, CNS, Hematology and Oncology.

Centralized Support Services:• Program Development & Start-up
• Contracting & Financial Services
• Regulatory & Safety
• Clinical Operations Support
• Global Quality & Education
• Technology Integration & SupportOur Differentiators:• Utilization of Central IRBs
• Rapid Study Activation Timelines
• Community Clinic-Based Model Provides Access to Larger Numbers of Patients
• Efficiencies With Budget, Contract, and Informed Consent Negotiations
• Standardized SOPs and Quality Metrics Across All Capsicure Approved Sites

• Our Services Portfolio

THE CURATVLY 7 SUITE FRAMEWORK

THE 7 INTERDEPENDENT ELEMENTS

Our Customized Objectives

Our Disruptive Solution

WHY CAPSICURE?

We solve tough, complex problems by combining deep industry knowledge, rigorous analysis and unparalleled insight to enable confident action.